دورية أكاديمية

Race as a factor for intensification of diabetes medications.

التفاصيل البيبلوغرافية
العنوان: Race as a factor for intensification of diabetes medications.
المؤلفون: Bullock KC; Texas Tech University Health Sciences Center School of Pharmacy, Department of Pharmacy Practice; Veterans Affairs North Texas Health Care System (VANTHCS), Dallas, Texas (Dr Bullock, Dr Edwards, Dr Greene, Dr Shah, Dr Blaszczyk), Edwards KL; Texas Tech University Health Sciences Center School of Pharmacy, Department of Pharmacy Practice; Veterans Affairs North Texas Health Care System (VANTHCS), Dallas, Texas (Dr Bullock, Dr Edwards, Dr Greene, Dr Shah, Dr Blaszczyk), Greene RS; Texas Tech University Health Sciences Center School of Pharmacy, Department of Pharmacy Practice; Veterans Affairs North Texas Health Care System (VANTHCS), Dallas, Texas (Dr Bullock, Dr Edwards, Dr Greene, Dr Shah, Dr Blaszczyk), Shah SR; Texas Tech University Health Sciences Center School of Pharmacy, Department of Pharmacy Practice; Veterans Affairs North Texas Health Care System (VANTHCS), Dallas, Texas (Dr Bullock, Dr Edwards, Dr Greene, Dr Shah, Dr Blaszczyk), Blaszczyk AT; Texas Tech University Health Sciences Center School of Pharmacy, Department of Pharmacy Practice; Veterans Affairs North Texas Health Care System (VANTHCS), Dallas, Texas (Dr Bullock, Dr Edwards, Dr Greene, Dr Shah, Dr Blaszczyk)
المصدر: The Diabetes educator [Diabetes Educ] 2013 May-Jun; Vol. 39 (3), pp. 335-43. Date of Electronic Publication: 2013 Mar 08.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Sage Publications, Country of Publication: United States NLM ID: 7701401 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1554-6063 (Electronic) Linking ISSN: 01457217 NLM ISO Abbreviation: Diabetes Educ
أسماء مطبوعة: Publication: Thousand Oaks, Calif. : Sage Publications, : American Assn. of Diabetes Educators
Original Publication: Chicago, American Assn. of Diabetes Educators.
مواضيع طبية MeSH: Black or African American* , Hispanic or Latino* , Veterans*, Diabetes Mellitus, Type 2/*ethnology , Health Services Accessibility/*statistics & numerical data , Hyperglycemia/*ethnology , Hypoglycemic Agents/*therapeutic use , Insulin/*therapeutic use, Analysis of Variance ; Diabetes Mellitus, Type 2/drug therapy ; Diabetes Mellitus, Type 2/epidemiology ; Female ; Glycated Hemoglobin/metabolism ; Healthcare Disparities/statistics & numerical data ; Humans ; Hyperglycemia/drug therapy ; Hyperglycemia/epidemiology ; Male ; Middle Aged ; Outpatients ; Retrospective Studies ; Texas/epidemiology ; United States/epidemiology ; United States Department of Veterans Affairs
مستخلص: Purpose: The purpose of this study was to investigate if patients of nonwhite race are less likely to receive insulin therapy for treatment of poorly controlled diabetes than patients of white race.
Methods: A retrospective review was performed of patients with an A1C >10%. The primary objective was to determine any difference in the initiation of insulin between white and nonwhite patients. Secondary outcomes measured the impact of clinic type and provider specialty on the initiation of insulin therapy. Exclusion criteria included those patients with type 1 diabetes mellitus, those who were previously receiving insulin, and those without an outpatient clinic visit within 14 days of an A1C >10%.
Results: A total of 277 patients were included. Of these patients, 132 (47.7%) were white, followed by 95 (34.2%) black non-Hispanic patients and 30 (10.8%) Hispanic/Latino patients. No difference was found in receipt of insulin therapy for nonwhite patients as compared to white patients (12.5 vs 21.4, P = .117). Neither clinic type nor provider specialty impacted initiation of insulin therapy. No changes to medication regimen were made at 35% of clinic visits.
Conclusions: Failure to intensify diabetic medications was common in this outpatient setting. There were no disparities in the receipt of insulin therapy between white and nonwhite patients.
المشرفين على المادة: 0 (Glycated Hemoglobin A)
0 (Hypoglycemic Agents)
0 (Insulin)
0 (hemoglobin A1c protein, human)
تواريخ الأحداث: Date Created: 20130312 Date Completed: 20140122 Latest Revision: 20221207
رمز التحديث: 20221213
DOI: 10.1177/0145721713479145
PMID: 23475185
قاعدة البيانات: MEDLINE
الوصف
تدمد:1554-6063
DOI:10.1177/0145721713479145